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Background
Sub-Saharan Africa (SSA) remains the region most
affected by HIV. A safe, effective and accessible vaccine is
required to complement the existing HIV/AIDS preven-
tion strategies. Until recently, HIV vaccine research was
conducted mainly in the developed world, but increas-
ingly is taking place in developing countries. In recent
years capacity for such research has been developed in SSA
through the support of international partners. With the
growing mandate to conduct HIV prevention research in
Africa, there is need to sustain and complement this
capacity building by supporting South-South networks to
strengthen the existing experience and expertise.
Methods
Through a 3 year grant from the European and Develop-
ing Countries Clinical Trials Partnerships (EDCTP) and
with the support of partners such as the International
AIDS Vaccine Initiative (IAVI), South-South collaboration
has been established between the Uganda Virus Research
Institute (UVRI) and the Malawi-Liverpool-Welcome
Trust Clinical Research Programme (MLW). The main
focus of this collaboration is on cohort development for
future HIV vaccine trials, technology transfer, training in
Good Clinical Practice (GCP) and Good Clinical Labora-
tory Practice (GCLP) and social science studies and project
management methodologies. Common research goals
have been identified and implemented via exchange vis-
its, conference calls and participation in training work-
shops, creating a strong South-South synergy.
Results
Partners collaborated to develop similar protocols to
recruit high risk individuals from fishing communities of
Lake Victoria and Lake Malawi into a prospective study
integrating epidemiology, social science and virology.
Methodologies for the recruitment and retention of these
marginalized populations are shared between partners
and will hopefully lead to great potential for future HIV
vaccine research.
Conclusion
We have observed that South-South experience and capac-
ity sharing is mutually beneficial and supports African sci-
entists in the conduct of relevant research in SSA for the
benefit of the global HIV vaccine effort.
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